Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 22, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012977.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
COORDINATES: polyA evidence [ECO:0006239]
DPY30 domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
DPY30 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DPY30 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 25 member 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
solute carrier family 25 member 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
graves disease carrier protein isoform X1
graves disease carrier protein isoform X2
eukaryotic translation initiation factor 4E family member 1c, transcript variant X2
eukaryotic translation initiation factor 4E family member 1c isoform X2
eukaryotic translation initiation factor 4E family member 1c, transcript variant X1
eukaryotic translation initiation factor 4E family member 1c isoform X1
DNA replication helicase/nuclease 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA replication helicase/nuclease 2, transcript variant X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X1
DNA replication helicase/nuclease 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X2
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X1
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X2
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X4
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H3 isoform X1
heterogeneous nuclear ribonucleoprotein H3 isoform X2
heterogeneous nuclear ribonucleoprotein H3 isoform X3
heterogeneous nuclear ribonucleoprotein H3 isoform X4
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X6
heterogeneous nuclear ribonucleoprotein H3 isoform X5
heterogeneous nuclear ribonucleoprotein H3 (2H9), transcript variant X7
heterogeneous nuclear ribonucleoprotein H3 isoform X6
RUN and FYVE domain containing 2, transcript variant X2
RUN and FYVE domain containing 2, transcript variant X3
RUN and FYVE domain containing 2, transcript variant X1
RUN and FYVE domain containing 2, transcript variant X4
RUN and FYVE domain-containing protein 2 isoform X3
RUN and FYVE domain-containing protein 2 isoform X4
RUN and FYVE domain-containing protein 2 isoform X2
RUN and FYVE domain-containing protein 2 isoform X1
RUN and FYVE domain containing 2, transcript variant X6
RUN and FYVE domain containing 2, transcript variant X5
RUN and FYVE domain-containing protein 2 isoform X6
RUN and FYVE domain-containing protein 2 isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC100535981 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC100535981 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC100535981 homolog, transcript variant X1
uncharacterized protein si:ch211-250c4.3 isoform X3
uncharacterized protein LOC100535981 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein si:ch211-250c4.3 isoform X2
uncharacterized protein LOC100535981 homolog, transcript variant X5
uncharacterized protein si:ch211-250c4.3 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ (Hsp40) homolog, subfamily C, member 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dnaJ homolog subfamily C member 12 isoform X2
dnaJ homolog subfamily C member 12 isoform X1
NAD-dependent protein deacetylase sirtuin-1
uncharacterized LOC122561007, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC122561007, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytochrome c oxidase subunit 5B, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X1
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X4
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X3
probable E3 ubiquitin-protein ligase HERC4 isoform X1
probable E3 ubiquitin-protein ligase HERC4 isoform X2
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polycystic kidney disease 2-like 1 protein
protein phosphatase 1K, mitochondrial-like
broad substrate specificity ATP-binding cassette transporter ABCG2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
helicase, lymphoid specific, transcript variant X3
helicase, lymphoid specific, transcript variant X2
helicase, lymphoid specific, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
solute carrier family 22 member 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 22 member 15, transcript variant X1
solute carrier family 22 member 15, transcript variant X3
solute carrier family 22 member 15 isoform X1
solute carrier family 22 member 15 isoform X2
receptor expression-enhancing protein 3-like, transcript variant X2
receptor expression-enhancing protein 3-like, transcript variant X1
receptor expression-enhancing protein 3-like
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X5
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X2
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X6
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable JmjC domain-containing histone demethylation protein 2C isoform X2
probable JmjC domain-containing histone demethylation protein 2C isoform X1
probable JmjC domain-containing histone demethylation protein 2C isoform X5
probable JmjC domain-containing histone demethylation protein 2C isoform X4
probable JmjC domain-containing histone demethylation protein 2C isoform X3
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
probable JmjC domain-containing histone demethylation protein 2C
nuclear receptor binding factor 2b, transcript variant X1
nuclear receptor binding factor 2b, transcript variant X3
nuclear receptor binding factor 2b, transcript variant X2
nuclear receptor-binding factor 2b isoform X1
nuclear receptor-binding factor 2b isoform X2
2-aminoethanethiol (cysteamine) dioxygenase a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
AT-rich interaction domain 5B, transcript variant X1
AT-rich interaction domain 5B, transcript variant X2
AT-rich interaction domain 5B, transcript variant X3
AT-rich interaction domain 5B, transcript variant X4
AT-rich interactive domain-containing protein 5B isoform X2
AT-rich interactive domain-containing protein 5B isoform X1
AT-rich interactive domain-containing protein 5B isoform X3
AT-rich interactive domain-containing protein 5B isoform X4
ciliary associated calcium binding coiled-coil 1
ciliary-associated calcium-binding coiled-coil protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho related BTB domain containing 1, transcript variant X2
Rho related BTB domain containing 1, transcript variant X5
Rho related BTB domain containing 1, transcript variant X3
Rho related BTB domain containing 1, transcript variant X1
rho-related BTB domain-containing protein 1 isoform X1
rho-related BTB domain-containing protein 1 isoform X2
Rho related BTB domain containing 1, transcript variant X6
Rho related BTB domain containing 1, transcript variant X4
rho-related BTB domain-containing protein 1 isoform X3
rho-related BTB domain-containing protein 1 isoform X4
cyclin-dependent kinase 1, transcript variant X2
cyclin-dependent kinase 1, transcript variant X1
cyclin-dependent kinase 1, transcript variant X3
coiled-coil domain-containing protein 6b
family with sequence similarity 13 member C, transcript variant X2
family with sequence similarity 13 member C, transcript variant X1
family with sequence similarity 13 member C, transcript variant X6
family with sequence similarity 13 member C, transcript variant X3
family with sequence similarity 13 member C, transcript variant X5
family with sequence similarity 13 member C, transcript variant X7
family with sequence similarity 13 member C, transcript variant X4
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X1
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X4
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X3
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X2
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X5
phytanoyl-CoA hydroxylase-interacting protein-like
protein bicaudal C homolog 1-like, transcript variant X1
protein bicaudal C homolog 1-like, transcript variant X3
protein bicaudal C homolog 1-like, transcript variant X4
protein bicaudal C homolog 1-like isoform X3
protein bicaudal C homolog 1-like isoform X1
protein bicaudal C homolog 1-like isoform X4
protein bicaudal C homolog 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein bicaudal C homolog 1-like isoform X2
transcription factor A, mitochondrial, transcript variant X1
transcription factor A, mitochondrial, transcript variant X2
transcription factor A, mitochondrial isoform X1
transcription factor A, mitochondrial isoform X2
ubiquitin-conjugating enzyme E2D 1b, transcript variant X3
ubiquitin-conjugating enzyme E2D 1b, transcript variant X1
ubiquitin-conjugating enzyme E2D 1b, transcript variant X2
ubiquitin-conjugating enzyme E2 D1b isoform X3
ubiquitin-conjugating enzyme E2 D1b isoform X1
ubiquitin-conjugating enzyme E2 D1b isoform X2
ubiquitin-conjugating enzyme E2D 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2D 1b, transcript variant X4
ubiquitin-conjugating enzyme E2 D1b isoform X4
CDGSH iron-sulfur domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
dickkopf WNT signaling pathway inhibitor 1b
protocadherin-related 15b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protocadherin-related 15b, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
apobec1 complementation factor, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
apobec1 complementation factor, transcript variant X1
apobec1 complementation factor, transcript variant X4
apobec1 complementation factor, transcript variant X3
apobec1 complementation factor, transcript variant X6
apobec1 complementation factor, transcript variant X7
apobec1 complementation factor, transcript variant X2
apobec1 complementation factor, transcript variant X5
apobec1 complementation factor, transcript variant X8
APOBEC1 complementation factor isoform X9
APOBEC1 complementation factor isoform X1
APOBEC1 complementation factor isoform X4
APOBEC1 complementation factor isoform X3
APOBEC1 complementation factor isoform X6
APOBEC1 complementation factor isoform X7
APOBEC1 complementation factor isoform X2
APOBEC1 complementation factor isoform X5
APOBEC1 complementation factor isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
sphingomyelin synthase 1b, transcript variant X3
sphingomyelin synthase 1b, transcript variant X4
sphingomyelin synthase 1b, transcript variant X1
sphingomyelin synthase 1b, transcript variant X2
phosphatidylcholine:ceramide cholinephosphotransferase 1 isoform X2
phosphatidylcholine:ceramide cholinephosphotransferase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
multiple inositol-polyphosphate phosphatase 1b, transcript variant X1
multiple inositol-polyphosphate phosphatase 1b, transcript variant X5
multiple inositol-polyphosphate phosphatase 1b, transcript variant X3
multiple inositol-polyphosphate phosphatase 1b, transcript variant X2
multiple inositol-polyphosphate phosphatase 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
multiple inositol-polyphosphate phosphatase 1b, transcript variant X6
multiple inositol polyphosphate phosphatase 1b isoform X1
multiple inositol polyphosphate phosphatase 1b isoform X2
multiple inositol polyphosphate phosphatase 1b isoform X5
multiple inositol polyphosphate phosphatase 1b isoform X3
multiple inositol polyphosphate phosphatase 1b isoform X4
multiple inositol polyphosphate phosphatase 1b isoform X6
3'-phosphoadenosine 5'-phosphosulfate synthase 2b
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2b
ATPase family AAA domain containing 1b, transcript variant X2
ATPase family AAA domain containing 1b, transcript variant X1
outer mitochondrial transmembrane helix translocase isoform X1
outer mitochondrial transmembrane helix translocase isoform X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
renalase, FAD-dependent amine oxidase, transcript variant X7
renalase, FAD-dependent amine oxidase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
renalase, FAD-dependent amine oxidase, transcript variant X4
renalase, FAD-dependent amine oxidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
renalase, FAD-dependent amine oxidase, transcript variant X2
renalase, FAD-dependent amine oxidase, transcript variant X5
renalase, FAD-dependent amine oxidase, transcript variant X3
ankyrin repeat domain 22, transcript variant X2
ankyrin repeat domain 22, transcript variant X1
ankyrin repeat domain 22, transcript variant X3
ankyrin repeat domain-containing protein 22 isoform X2
ankyrin repeat domain-containing protein 22 isoform X1
ankyrin repeat domain-containing protein 22 isoform X3
STAM binding protein-like 1, transcript variant X1
STAM binding protein-like 1, transcript variant X6
STAM binding protein-like 1, transcript variant X5
STAM binding protein-like 1, transcript variant X4
STAM binding protein-like 1, transcript variant X2
STAM binding protein-like 1, transcript variant X3
tumor necrosis factor receptor superfamily member 6-like, transcript variant X2
tumor necrosis factor receptor superfamily member 6-like isoform X2
tumor necrosis factor receptor superfamily member 6-like, transcript variant X3
tumor necrosis factor receptor superfamily member 6-like, transcript variant X1
tumor necrosis factor receptor superfamily member 6-like isoform X1
tumor necrosis factor receptor superfamily member 6-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
interferon-induced protein with tetratricopeptide repeats 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
interferon-induced protein with tetratricopeptide repeats 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
interferon-induced protein with tetratricopeptide repeats 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 1-like isoform X2
interferon-induced protein with tetratricopeptide repeats 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 5-like, transcript variant X2
interferon-induced protein with tetratricopeptide repeats 5-like, transcript variant X3
interferon-induced protein with tetratricopeptide repeats 5-like isoform X2
interferon-induced protein with tetratricopeptide repeats 5-like, transcript variant X1
interferon-induced protein with tetratricopeptide repeats 5-like isoform X1
interferon-induced protein with tetratricopeptide repeats 5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 5-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monocarboxylate transporter 12-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
monocarboxylate transporter 12-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
monocarboxylate transporter 12-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
monocarboxylate transporter 12-like, transcript variant X1
5-hydroxytryptamine receptor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
5-hydroxytryptamine receptor 7 isoform X2
5-hydroxytryptamine receptor 7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ribonuclease P/MRP 30 subunit, transcript variant X2
ribonuclease P/MRP 30 subunit, transcript variant X3
ribonuclease P/MRP 30 subunit, transcript variant X1
ribonuclease P/MRP 30 subunit, transcript variant X4
ribonuclease P/MRP 30 subunit, transcript variant X5
ribonuclease P protein subunit p30 isoform X1
ribonuclease P protein subunit p30 isoform X3
ribonuclease P protein subunit p30 isoform X2
ankyrin repeat domain 1b (cardiac muscle)
ankyrin repeat domain-containing protein 1b
polycomb group ring finger 5b, transcript variant X1
polycomb group ring finger 5b, transcript variant X4
polycomb group ring finger 5b, transcript variant X2
polycomb group ring finger 5b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
probable E3 ubiquitin-protein ligase HECTD2
protein phosphatase 1, regulatory subunit 3Cb, transcript variant X1
protein phosphatase 1, regulatory subunit 3Cb, transcript variant X3
protein phosphatase 1, regulatory subunit 3Cb, transcript variant X2
protein phosphatase 1 regulatory subunit 3C-B isoform X1
protein phosphatase 1 regulatory subunit 3C-B isoform X2
protein phosphatase 1 regulatory subunit 3C-B isoform X3
poly [ADP-ribose] polymerase tankyrase-2-like
fibroblast growth factor binding protein 3
fibroblast growth factor-binding protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TBC1 domain family, member 12b, transcript variant X5
TBC1 domain family, member 12b, transcript variant X6
TBC1 domain family, member 12b, transcript variant X1
TBC1 domain family, member 12b, transcript variant X2
TBC1 domain family, member 12b, transcript variant X3
TBC1 domain family, member 12b, transcript variant X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
leucine-rich glioma-inactivated protein 1b
phosphodiesterase 6C, cGMP-specific, cone, alpha prime
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cytochrome P450 26A1, transcript variant X2
cytochrome P450 26A1, transcript variant X1
cytochrome P450 26B1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytochrome P450 26B1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 26B1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
exocyst complex component 6-like, transcript variant X9
exocyst complex component 6-like, transcript variant X4
exocyst complex component 6-like, transcript variant X1
exocyst complex component 6-like, transcript variant X6
exocyst complex component 6-like, transcript variant X2
exocyst complex component 6-like, transcript variant X3
exocyst complex component 6-like, transcript variant X11
exocyst complex component 6-like, transcript variant X8
exocyst complex component 6-like, transcript variant X5
exocyst complex component 6-like isoform X6
exocyst complex component 6-like isoform X4
exocyst complex component 6-like isoform X2
exocyst complex component 6-like isoform X1
exocyst complex component 6-like isoform X8
exocyst complex component 6-like isoform X11
exocyst complex component 6-like isoform X5
exocyst complex component 6-like isoform X3
exocyst complex component 6-like isoform X9
exocyst complex component 6-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
exocyst complex component 6-like isoform X7
exocyst complex component 6-like, transcript variant X10
exocyst complex component 6-like isoform X10
hematopoietically-expressed homeobox protein hhex
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
insulin-degrading enzyme, transcript variant X2
insulin-degrading enzyme, transcript variant X1
insulin-degrading enzyme, transcript variant X4
insulin-degrading enzyme, transcript variant X5
insulin-degrading enzyme, transcript variant X3
membrane-associated ring finger (C3HC4) 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic polyadenylation element binding protein 3, transcript variant X3
cytoplasmic polyadenylation element binding protein 3, transcript variant X5
cytoplasmic polyadenylation element binding protein 3, transcript variant X1
cytoplasmic polyadenylation element binding protein 3, transcript variant X2
cytoplasmic polyadenylation element-binding protein 3 isoform X1
cytoplasmic polyadenylation element-binding protein 3 isoform X2
cytoplasmic polyadenylation element binding protein 3, transcript variant X4
cytoplasmic polyadenylation element-binding protein 3 isoform X3
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, transcript variant X2
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, transcript variant X1
TATA-binding protein-associated factor 172 isoform X2
TATA-binding protein-associated factor 172 isoform X1
RNA/RNP complex-1-interacting phosphatase-like, transcript variant X1
RNA/RNP complex-1-interacting phosphatase-like, transcript variant X2
RNA/RNP complex-1-interacting phosphatase-like
coiled-coil and C2 domain-containing protein 2A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
deoxynucleotidyltransferase, terminal, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
deoxynucleotidyltransferase, terminal, transcript variant X2
DNA nucleotidylexotransferase isoform X1
DNA nucleotidylexotransferase isoform X2
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X4
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X7
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X13
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X12
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X15
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X11
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X14
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X6
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X8
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X10
heparan sulfate glucosamine 3-O-sulfotransferase 1-like
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X1
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X9
kinase non-catalytic C-lobe domain-containing protein 1 isoform X5
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X3
kinase non-catalytic C-lobe domain-containing protein 1 isoform X1
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X5
kinase non-catalytic C-lobe domain-containing protein 1 isoform X3
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X8
homeobox protein vex1-like, transcript variant X3
homeobox protein vex1-like, transcript variant X1
homeobox protein vex1-like, transcript variant X2
homeobox protein vex1-like, transcript variant X4
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X7
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinase non-catalytic C-lobe domain-containing protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122561111, transcript variant X2
uncharacterized LOC122561111, transcript variant X1
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X4
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X11
kinase non-catalytic C-lobe domain-containing protein 1 isoform X2
kinase non-catalytic C-lobe domain-containing protein 1 isoform X6
kinase non-catalytic C-lobe domain-containing protein 1 isoform X7
cilia- and flagella-associated protein 46
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 146 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
inositol polyphosphate-5-phosphatase A, transcript variant X1
inositol polyphosphate-5-phosphatase A, transcript variant X2
inositol polyphosphate-5-phosphatase A isoform X1
inositol polyphosphate-5-phosphatase A isoform X2
PWWP domain containing 2B, transcript variant X3
PWWP domain containing 2B, transcript variant X1
PWWP domain containing 2B, transcript variant X2
PWWP domain containing 2B, transcript variant X4
leucine-rich repeat-containing protein 27-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase 32C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein kinase 32C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase 32C, transcript variant X3
serine/threonine-protein kinase 32C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase 32C isoform X1
serine/threonine-protein kinase 32C isoform X2
serine/threonine-protein kinase 32C isoform X3
dihydropyrimidinase-related protein 2-like, transcript variant X1
dihydropyrimidinase-related protein 2-like, transcript variant X2
dihydropyrimidinase-related protein 2-like isoform X1
dihydropyrimidinase-related protein 2-like isoform X2
Janus kinase and microtubule interacting protein 3, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X11
Janus kinase and microtubule interacting protein 3, transcript variant X10
Janus kinase and microtubule interacting protein 3, transcript variant X9
Janus kinase and microtubule interacting protein 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X7
Janus kinase and microtubule interacting protein 3, transcript variant X6
Janus kinase and microtubule interacting protein 3, transcript variant X4
Janus kinase and microtubule interacting protein 3, transcript variant X1
Janus kinase and microtubule interacting protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X5
Janus kinase and microtubule interacting protein 3, transcript variant X3
janus kinase and microtubule-interacting protein 3 isoform X7
janus kinase and microtubule-interacting protein 3 isoform X6
janus kinase and microtubule-interacting protein 3 isoform X5
janus kinase and microtubule-interacting protein 3 isoform X4
janus kinase and microtubule-interacting protein 3 isoform X3
janus kinase and microtubule-interacting protein 3 isoform X2
janus kinase and microtubule-interacting protein 3 isoform X1
Janus kinase and microtubule interacting protein 3, transcript variant X19
Janus kinase and microtubule interacting protein 3, transcript variant X18
Janus kinase and microtubule interacting protein 3, transcript variant X17
Janus kinase and microtubule interacting protein 3, transcript variant X20
Janus kinase and microtubule interacting protein 3, transcript variant X16
Janus kinase and microtubule interacting protein 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
janus kinase and microtubule-interacting protein 3 isoform X13
janus kinase and microtubule-interacting protein 3 isoform X12
janus kinase and microtubule-interacting protein 3 isoform X11
janus kinase and microtubule-interacting protein 3 isoform X14
janus kinase and microtubule-interacting protein 3 isoform X10
janus kinase and microtubule-interacting protein 3 isoform X9
janus kinase and microtubule-interacting protein 3 isoform X8
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3
protein phosphatase 2, regulatory subunit B, delta, transcript variant X1
protein phosphatase 2, regulatory subunit B, delta, transcript variant X2
protein phosphatase 2, regulatory subunit B, delta, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X2
protein phosphatase 2, regulatory subunit B, delta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X3
uncharacterized LOC122561125, transcript variant X1
uncharacterized LOC122561125, transcript variant X2
transcription elongation regulator 1-like protein, transcript variant X4
transcription elongation regulator 1-like protein, transcript variant X1
transcription elongation regulator 1-like protein, transcript variant X3
transcription elongation regulator 1-like protein, transcript variant X2
transcription elongation regulator 1-like protein isoform X2
transcription elongation regulator 1-like protein isoform X1
transcription elongation regulator 1-like protein, transcript variant X5
transcription elongation regulator 1-like protein isoform X3
EBF transcription factor 3a, transcript variant X2
EBF transcription factor 3a, transcript variant X1
EBF transcription factor 3a, transcript variant X4
EBF transcription factor 3a, transcript variant X6
EBF transcription factor 3a, transcript variant X5
EBF transcription factor 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
methylated-DNA--protein-cysteine methyltransferase
protein tyrosine phosphatase receptor type Ea
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase epsilon
uncharacterized LOC122561137, transcript variant X4
uncharacterized LOC122561137, transcript variant X6
uncharacterized LOC122561137, transcript variant X7
uncharacterized LOC122561137, transcript variant X5
uncharacterized LOC122561137, transcript variant X2
uncharacterized LOC122561137, transcript variant X1
uncharacterized LOC122561137, transcript variant X3
uncharacterized LOC122561137, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome 22 C10orf90 homolog, transcript variant X1
chromosome 22 C10orf90 homolog, transcript variant X2
(E2-independent) E3 ubiquitin-conjugating enzyme FATS
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 12 isoform X1
disintegrin and metalloproteinase domain-containing protein 12 isoform X3
disintegrin and metalloproteinase domain-containing protein 12 isoform X2
disintegrin and metalloproteinase domain-containing protein 12 isoform X4
fibronectin type III and ankyrin repeat domains 1, transcript variant X6
fibronectin type III and ankyrin repeat domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibronectin type III and ankyrin repeat domains 1, transcript variant X4
fibronectin type III and ankyrin repeat domains 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibronectin type III and ankyrin repeat domains 1, transcript variant X2
fibronectin type III and ankyrin repeat domains 1, transcript variant X3
fibronectin type 3 and ankyrin repeat domains protein 1 isoform X2
fibronectin type 3 and ankyrin repeat domains protein 1 isoform X1
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BRCA2 and CDKN1A interacting protein, transcript variant X2
BRCA2 and CDKN1A interacting protein, transcript variant X1
uroporphyrinogen III synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uroporphyrinogen III synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uroporphyrinogen-III synthase isoform X2
uroporphyrinogen-III synthase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
erythroid differentiation regulatory factor 1, transcript variant X2
erythroid differentiation regulatory factor 1, transcript variant X1
erythroid differentiation-related factor 1 isoform X2
erythroid differentiation-related factor 1 isoform X1
erythroid differentiation regulatory factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
erythroid differentiation-related factor 1 isoform X3
erythroid differentiation regulatory factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
erythroid differentiation-related factor 1 isoform X5
erythroid differentiation regulatory factor 1, transcript variant X4
erythroid differentiation-related factor 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, RAN-binding domain containing 1a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
EEF1A lysine methyltransferase 2, transcript variant X2
EEF1A lysine methyltransferase 2, transcript variant X3
EEF1A lysine methyltransferase 2, transcript variant X4
EEF1A lysine methyltransferase 2 isoform X4
EEF1A lysine methyltransferase 2 isoform X3
EEF1A lysine methyltransferase 2 isoform X2
EEF1A lysine methyltransferase 2, transcript variant X1
EEF1A lysine methyltransferase 2 isoform X1
family with sequence similarity 53 member B, transcript variant X2
family with sequence similarity 53 member B, transcript variant X1
family with sequence similarity 53 member B, transcript variant X3
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X3
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X1
phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X3
phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X1
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X2
phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X2
NK1 transcription factor related 2-like,a, transcript variant X1
NK1 transcription factor related 2-like,a, transcript variant X2
NK1 transcription factor related 2-like,a isoform X2
NK1 transcription factor related 2-like,a isoform X1
ornithine aminotransferase, transcript variant X2
ornithine aminotransferase, transcript variant X3
ornithine aminotransferase, transcript variant X5
ornithine aminotransferase, transcript variant X1
ornithine aminotransferase, transcript variant X4
ornithine aminotransferase, mitochondrial
carbohydrate sulfotransferase 15-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
carbohydrate sulfotransferase 15-like, transcript variant X1
carbohydrate sulfotransferase 15-like, transcript variant X2
carbohydrate sulfotransferase 15-like, transcript variant X3
carbohydrate sulfotransferase 15-like isoform X1
carbohydrate sulfotransferase 15-like isoform X2
submandibular gland secretory Glx-rich protein CB-like
carboxypeptidase X (M14 family), member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inactive carboxypeptidase-like protein X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized si:zfos-911d5.4, transcript variant X2
uncharacterized si:zfos-911d5.4, transcript variant X1
uncharacterized protein si:zfos-911d5.4 isoform X1
uncharacterized protein si:zfos-911d5.4 isoform X2
homeobox protein HMX2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
homeobox protein HMX2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeobox protein HMX2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
acyl-CoA dehydrogenase short/branched chain, transcript variant X2
short/branched chain specific acyl-CoA dehydrogenase, mitochondrial isoform X2
acyl-CoA dehydrogenase short/branched chain, transcript variant X1
short/branched chain specific acyl-CoA dehydrogenase, mitochondrial isoform X1
uncharacterized protein LOC570656 homolog
disintegrin and metalloproteinase domain-containing protein 9
deleted in malignant brain tumors 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
deleted in malignant brain tumors 1 protein-like, transcript variant X5
deleted in malignant brain tumors 1 protein-like, transcript variant X4
deleted in malignant brain tumors 1 protein-like, transcript variant X3
deleted in malignant brain tumors 1 protein-like, transcript variant X2
deleted in malignant brain tumors 1 protein-like, transcript variant X1
deleted in malignant brain tumors 1 protein-like isoform X1
deleted in malignant brain tumors 1 protein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81% coverage of the annotated genomic feature by RNAseq alignments
transforming acidic coiled-coil-containing protein 2-like, transcript variant X1
transforming acidic coiled-coil-containing protein 2-like, transcript variant X2
transforming acidic coiled-coil-containing protein 2-like isoform X1
transforming acidic coiled-coil-containing protein 2-like isoform X2
BTB (POZ) domain containing 16, transcript variant X2
BTB/POZ domain-containing protein 16 isoform X2
BTB (POZ) domain containing 16, transcript variant X1
BTB/POZ domain-containing protein 16 isoform X1
BTB (POZ) domain containing 16, transcript variant X3
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X3
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X1
pleckstrin homology domain-containing family A member 1 isoform X1
pleckstrin homology domain-containing family A member 1 isoform X2
pleckstrin homology domain-containing family A member 1 isoform X3
pleckstrin homology domain-containing family A member 1 isoform X4
HtrA serine peptidase 1b, transcript variant X3
HtrA serine peptidase 1b, transcript variant X4
HtrA serine peptidase 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
HtrA serine peptidase 1b, transcript variant X1
NSE4 homolog A, SMC5-SMC6 complex component
non-structural maintenance of chromosomes element 4 homolog A
arginyl-tRNA--protein transferase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1 isoform X2
arginyl-tRNA--protein transferase 1 isoform X10
arginyl-tRNA--protein transferase 1 isoform X9
arginyl-tRNA--protein transferase 1 isoform X5
arginyl-tRNA--protein transferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1 isoform X8
arginyl-tRNA--protein transferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1, transcript variant X4
arginyl-tRNA--protein transferase 1, transcript variant X7
arginyl-tRNA--protein transferase 1, transcript variant X1
arginyl-tRNA--protein transferase 1 isoform X3
arginyl-tRNA--protein transferase 1 isoform X4
arginyl-tRNA--protein transferase 1 isoform X7
arginyl-tRNA--protein transferase 1 isoform X1
arginyl-tRNA--protein transferase 1, transcript variant X6
arginyl-tRNA--protein transferase 1 isoform X6
uncharacterized LOC122561179, transcript variant X2
uncharacterized LOC122561179, transcript variant X1
fibroblast growth factor receptor 2-like
phospholipid phosphatase 4, transcript variant X1
phospholipid phosphatase 4, transcript variant X2
SEC23 interacting protein, transcript variant X1
SEC23 interacting protein, transcript variant X2
minichromosome maintenance complex binding protein
mini-chromosome maintenance complex-binding protein
inositol polyphosphate-5-phosphatase F, transcript variant X3
inositol polyphosphate-5-phosphatase F, transcript variant X2
inositol polyphosphate-5-phosphatase F, transcript variant X1
phosphatidylinositide phosphatase SAC2 isoform X2
phosphatidylinositide phosphatase SAC2 isoform X1
BAG family molecular chaperone regulator 3
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X1
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X2
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X3
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X4
regulator of G-protein signaling 10-like
G protein-coupled receptor kinase 5-like, transcript variant X3
G protein-coupled receptor kinase 5-like isoform X3
G protein-coupled receptor kinase 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
G protein-coupled receptor kinase 5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein-coupled receptor kinase 5-like isoform X4
G protein-coupled receptor kinase 5-like isoform X2
G protein-coupled receptor kinase 5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
G protein-coupled receptor kinase 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
G protein-coupled receptor kinase 5-like isoform X1
G protein-coupled receptor kinase 5-like isoform X5
U6 snRNA-associated Sm-like protein LSm1
thioredoxin-dependent peroxide reductase, mitochondrial isoform X1
thioredoxin-dependent peroxide reductase, mitochondrial isoform X2
EF-hand calcium-binding domain-containing protein 6-like, transcript variant X3
EF-hand calcium-binding domain-containing protein 6-like isoform X3
EF-hand calcium-binding domain-containing protein 6-like, transcript variant X1
EF-hand calcium-binding domain-containing protein 6-like, transcript variant X2
EF-hand calcium-binding domain-containing protein 6-like, transcript variant X4
EF-hand calcium-binding domain-containing protein 6-like isoform X1
EF-hand calcium-binding domain-containing protein 6-like isoform X2
uncharacterized protein LOC122561192 isoform X4
EF-hand calcium-binding domain-containing protein 6-like, transcript variant X5
EF-hand calcium-binding domain-containing protein 6-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA synthetase long chain family member 5
zinc finger DHHC-type palmitoyltransferase 6
vesicle transport through interaction with t-SNAREs 1A
vesicle transport through interaction with t-SNAREs homolog 1A
transcription factor 7 like 2, transcript variant X2
transcription factor 7 like 2, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X19
transcription factor 7 like 2, transcript variant X4
transcription factor 7 like 2, transcript variant X7
transcription factor 7 like 2, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X21
transcription factor 7 like 2, transcript variant X8
transcription factor 7 like 2, transcript variant X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X24
transcription factor 7 like 2, transcript variant X26
transcription factor 7 like 2, transcript variant X1
transcription factor 7 like 2, transcript variant X5
transcription factor 7 like 2, transcript variant X6
transcription factor 7 like 2, transcript variant X3
transcription factor 7 like 2, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X10
transcription factor 7 like 2, transcript variant X9
transcription factor 7 like 2, transcript variant X29
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X13
transcription factor 7 like 2, transcript variant X12
transcription factor 7 like 2, transcript variant X11
transcription factor 7-like 2 isoform X1
transcription factor 7-like 2 isoform X5
transcription factor 7-like 2 isoform X10
transcription factor 7-like 2 isoform X6
transcription factor 7-like 2 isoform X9
transcription factor 7-like 2 isoform X13
transcription factor 7-like 2 isoform X3
transcription factor 7-like 2 isoform X11
transcription factor 7-like 2 isoform X12
transcription factor 7-like 2 isoform X2
transcription factor 7-like 2 isoform X4
transcription factor 7-like 2 isoform X7
transcription factor 7-like 2 isoform X8
transcription factor 7-like 2 isoform X16
transcription factor 7-like 2 isoform X17
transcription factor 7-like 2 isoform X21
transcription factor 7-like 2 isoform X26
transcription factor 7-like 2 isoform X27
transcription factor 7-like 2 isoform X28
transcription factor 7-like 2 isoform X18
transcription factor 7-like 2 isoform X24
transcription factor 7-like 2 isoform X25
transcription factor 7-like 2 isoform X20
transcription factor 7-like 2 isoform X22
transcription factor 7-like 2 isoform X23
transcription factor 7-like 2 isoform X19
transcription factor 7 like 2, transcript variant X14
transcription factor 7 like 2, transcript variant X15
transcription factor 7-like 2 isoform X14
transcription factor 7-like 2 isoform X15
uncharacterized LOC122560972, transcript variant X2
uncharacterized LOC122560972, transcript variant X1
hyaluronan-binding protein 2-like, transcript variant X1
hyaluronan-binding protein 2-like, transcript variant X2
hyaluronan-binding protein 2-like isoform X1
hyaluronan-binding protein 2-like isoform X2
nebulin-related anchoring protein, transcript variant X2
nebulin-related anchoring protein, transcript variant X3
nebulin-related anchoring protein, transcript variant X1
nebulin-related-anchoring protein isoform X2
nebulin-related-anchoring protein isoform X3
nebulin-related-anchoring protein isoform X1
S-antigen protein-like, transcript variant X3
S-antigen protein-like, transcript variant X1
S-antigen protein-like, transcript variant X4
S-antigen protein-like, transcript variant X2
trans-Golgi network integral membrane protein TGN38-like isoform X2
trans-Golgi network integral membrane protein 1-like isoform X4
caspase 7, apoptosis-related cysteine peptidase, transcript variant X1
caspase 7, apoptosis-related cysteine peptidase, transcript variant X2
pleckstrin homology domain-containing family S member 1-like
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)
NHL repeat containing 2, transcript variant X3
NHL repeat containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NHL repeat-containing protein 2 isoform X3
NHL repeat-containing protein 2 isoform X1
NHL repeat containing 2, transcript variant X2
NHL repeat-containing protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 186, transcript variant X1
coiled-coil domain-containing protein 186, transcript variant X4
coiled-coil domain-containing protein 186, transcript variant X3
coiled-coil domain-containing protein 186, transcript variant X2
coiled-coil domain-containing protein 186, transcript variant X6
coiled-coil domain-containing protein 186 isoform X4
coiled-coil domain-containing protein 186 isoform X3
coiled-coil domain-containing protein 186 isoform X2
coiled-coil domain-containing protein 186 isoform X1
coiled-coil domain-containing protein 186 isoform X6
coiled-coil domain-containing protein 186, transcript variant X5
coiled-coil domain-containing protein 186 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
von Willebrand factor A domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
von Willebrand factor A domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 2
actin filament associated protein 1-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
actin filament-associated protein 1-like 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
actin-binding LIM protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
actin-binding LIM protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
actin-binding LIM protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
actin-binding LIM protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
actin-binding LIM protein 1-like, transcript variant X6
actin-binding LIM protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
actin-binding LIM protein 1-like isoform X3
actin-binding LIM protein 1-like isoform X4
actin-binding LIM protein 1-like isoform X1
actin-binding LIM protein 1-like isoform X2
actin-binding LIM protein 1-like isoform X5
actin-binding LIM protein 1-like isoform X6
FHF complex subunit HOOK interacting protein 2
TruB pseudouridine (psi) synthase family member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
TruB pseudouridine (psi) synthase family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TruB pseudouridine (psi) synthase family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
probable tRNA pseudouridine synthase 1 isoform X1
probable tRNA pseudouridine synthase 1 isoform X2
attractin-like 1b, transcript variant X1
attractin-like 1b, transcript variant X2
attractin-like 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 17% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 172
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pancreatic lipase-related protein 2-like
heat shock protein 12A, transcript variant X5
heat shock protein 12A, transcript variant X3
heat shock protein 12A, transcript variant X2
heat shock protein 12A, transcript variant X1
heat shock protein 12A, transcript variant X4
heat shock protein 12A, transcript variant X6
heat shock 70 kDa protein 12A isoform X2
heat shock 70 kDa protein 12A isoform X1
heat shock 70 kDa protein 12A isoform X3
heat shock 70 kDa protein 12A isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122561223, transcript variant X2
uncharacterized LOC122561223, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase, H+ transporting, lysosomal, V1 subunit B, member a
V-type proton ATPase subunit B, kidney isoform
potassium channel, subfamily K, member 18
solute carrier family 18 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 18 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 18 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
synaptic vesicular amine transporter isoform X1
synaptic vesicular amine transporter isoform X2
solute carrier family 18 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
synaptic vesicular amine transporter isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 142 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
family with sequence similarity 204 member A, transcript variant X3
family with sequence similarity 204 member A, transcript variant X2
family with sequence similarity 204 member A, transcript variant X1
prolactin-releasing peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins
CDK2-associated and cullin domain-containing protein 1
eukaryotic translation initiation factor 3, subunit 10 (theta)
eukaryotic translation initiation factor 3 subunit A
COORDINATES: nucleotide motif:Rfam:12.0:RF00413
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X4
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X6
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X5
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X7
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X3
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X1
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X2
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X1
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X4
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X2
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X3
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X8
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X5
SH3 and PX domains 2Aa, transcript variant X1
SH3 and PX domains 2Aa, transcript variant X2
SH3 and PX domain-containing protein 2A isoform X1
SH3 and PX domain-containing protein 2A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma coactivator-related protein 1-like
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 1 isoform X2
ectonucleoside triphosphate diphosphohydrolase 1 isoform X3
ectonucleoside triphosphate diphosphohydrolase 1 isoform X1
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X4
aldehyde dehydrogenase 18 family, member A1, transcript variant X2
aldehyde dehydrogenase 18 family, member A1, transcript variant X1
aldehyde dehydrogenase 18 family, member A1, transcript variant X3
delta-1-pyrroline-5-carboxylate synthase isoform X1
delta-1-pyrroline-5-carboxylate synthase isoform X2
polycomb group ring finger 6, transcript variant X2
polycomb group ring finger 6, transcript variant X3
polycomb group ring finger 6, transcript variant X1
polycomb group RING finger protein 6 isoform X1
polycomb group RING finger protein 6 isoform X2
polycomb group RING finger protein 6 isoform X3
internexin neuronal intermediate filament protein, alpha a
5'-nucleotidase, cytosolic IIa, transcript variant X1
5'-nucleotidase, cytosolic IIa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
STE20-like kinase a, transcript variant X3
STE20-like kinase a, transcript variant X2
STE20-like kinase a, transcript variant X1
STE20-like serine/threonine-protein kinase isoform X3
STE20-like serine/threonine-protein kinase isoform X2
STE20-like serine/threonine-protein kinase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
SWI5-dependent homologous recombination repair protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
swi5-dependent recombination DNA repair protein 1 homolog
cilia and flagella associated protein 43, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cilia and flagella associated protein 43, transcript variant X1
cilia- and flagella-associated protein 43 isoform X2
cilia- and flagella-associated protein 43 isoform X1
cilia and flagella associated protein 43, transcript variant X3
cilia- and flagella-associated protein 43 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
inositol 1,4,5-trisphosphate receptor-interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor-interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor-interacting protein
gamma-glutamyl hydrolase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gamma-glutamyl hydrolase-like, transcript variant X1
gamma-glutamyl hydrolase-like, transcript variant X4
gamma-glutamyl hydrolase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
calcium homeostasis modulator protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium homeostasis modulator protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
programmed cell death 11, transcript variant X2
programmed cell death 11, transcript variant X1
ATP synthase membrane subunit k, transcript variant X2
ATP synthase membrane subunit k, transcript variant X1
ATP synthase membrane subunit DAPIT, mitochondrial
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor
transcription initiation factor TFIID subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122561275, transcript variant X1
uncharacterized LOC122561275, transcript variant X2
uncharacterized protein LOC122561275 isoform X2
uncharacterized protein LOC122561275 isoform X1
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X22
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X24
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X14
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X7
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X12
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X6
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X10
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X9
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X13
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X27
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X19
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X11
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X18
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X17
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X15
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X20
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X8
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X16
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X25
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X28
solute carrier family 2, facilitated glucose transporter member 9-like isoform X3
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 9-like, transcript variant X4
solute carrier family 2, facilitated glucose transporter member 5-like isoform X1
solute carrier family 2, facilitated glucose transporter member 9-like isoform X2
solute carrier family 2, facilitated glucose transporter member 5-like isoform X4
solute carrier family 2, facilitated glucose transporter member 9-like isoform X5
fibroblast growth factor 8 b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 8 b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
F-box and WD repeat domain containing 4, transcript variant X1
F-box and WD repeat domain containing 4, transcript variant X3
F-box and WD repeat domain containing 4, transcript variant X2
F-box and WD repeat domain containing 4, transcript variant X4
F-box/WD repeat-containing protein 4 isoform X1
F-box/WD repeat-containing protein 4 isoform X3
F-box/WD repeat-containing protein 4 isoform X2
F-box/WD repeat-containing protein 4 isoform X4
deleted in primary ciliary dyskinesia homolog (mouse), transcript variant X1
deleted in primary ciliary dyskinesia homolog (mouse), transcript variant X2
polymerase (DNA directed), lambda, transcript variant X2
polymerase (DNA directed), lambda, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
polymerase (DNA directed), lambda, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X1
LIM domain binding 1a, transcript variant X3
LIM domain-binding protein 1-A isoform X1
LIM domain-binding protein 1-A isoform X3
LIM domain binding 1a, transcript variant X2
LIM domain-binding protein 1-A isoform X2
armadillo like helical domain containing 3
armadillo-like helical domain-containing protein 3
Kv channel-interacting protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Kv channel-interacting protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Kv channel-interacting protein 2-like isoform X3
Kv channel-interacting protein 2-like isoform X5
Kv channel-interacting protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kv channel-interacting protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Kv channel-interacting protein 2-like isoform X1
Kv channel-interacting protein 2-like isoform X4
Kv channel-interacting protein 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Kv channel-interacting protein 2-like isoform X6
Kv channel-interacting protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Kv channel-interacting protein 2-like isoform X2
dynamin binding protein, transcript variant X3
dynamin binding protein, transcript variant X4
dynamin binding protein, transcript variant X1
dynamin binding protein, transcript variant X2
ATP-binding cassette, sub-family C (CFTR/MRP), member 2, transcript variant X3
ATP-binding cassette, sub-family C (CFTR/MRP), member 2, transcript variant X2
ATP-binding cassette, sub-family C (CFTR/MRP), member 2, transcript variant X1
canalicular multispecific organic anion transporter 1 isoform X2
canalicular multispecific organic anion transporter 1 isoform X3
canalicular multispecific organic anion transporter 1 isoform X1
cutC copper transporter homolog (E. coli), transcript variant X4
cutC copper transporter homolog (E. coli), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cutC copper transporter homolog (E. coli), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cutC copper transporter homolog (E. coli), transcript variant X2
copper homeostasis protein cutC homolog isoform X2
copper homeostasis protein cutC homolog isoform X1
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytochrome c oxidase assembly protein COX15 homolog, transcript variant X1
cytochrome c oxidase assembly protein COX15 homolog isoform X1
cytochrome c oxidase assembly protein COX15 homolog, transcript variant X4
cytochrome c oxidase assembly protein COX15 homolog, transcript variant X3
cytochrome c oxidase assembly protein COX15 homolog, transcript variant X2
cytochrome c oxidase assembly protein COX15 homolog isoform X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 7, transcript variant X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 7, transcript variant X1
ST3 beta-galactoside alpha-2,3-sialyltransferase 7, transcript variant X4
ST3 beta-galactoside alpha-2,3-sialyltransferase 7, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 7 isoform X1
ST3 beta-galactoside alpha-2,3-sialyltransferase 7 isoform X2
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1, transcript variant X3
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1, transcript variant X2
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1, transcript variant X1
Hermansky-Pudlak syndrome 1 protein isoform X2
Hermansky-Pudlak syndrome 1 protein isoform X1
phosphatidylinositol 4-kinase type 2 alpha
phosphatidylinositol 4-kinase type 2-alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
exosome component 1, transcript variant X1
exosome complex component CSL4 isoform X1
exosome component 1, transcript variant X2
exosome complex component CSL4 isoform X2
palmitoyltransferase ZDHHC16B-like, transcript variant X1
palmitoyltransferase ZDHHC16B-like, transcript variant X2
palmitoyltransferase ZDHHC16B-like, transcript variant X3
palmitoyltransferase ZDHHC16B-like isoform X1
palmitoyltransferase ZDHHC16B-like isoform X2
MMS19 homolog, cytosolic iron-sulfur assembly component, transcript variant X1
MMS19 homolog, cytosolic iron-sulfur assembly component, transcript variant X2
MMS19 homolog, cytosolic iron-sulfur assembly component, transcript variant X3
MMS19 nucleotide excision repair protein homolog isoform X1
MMS19 nucleotide excision repair protein homolog isoform X2
zinc finger protein interacting with ribonucleoprotein K-like, transcript variant X1
zinc finger protein Gfi-1b-like isoform X1
zinc finger protein interacting with ribonucleoprotein K-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
zinc finger protein interacting with ribonucleoprotein K-like isoform X2
ankyrin repeat domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
4-hydroxy-2-oxoglutarate aldolase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein, transcript variant X2
zinc finger protein, transcript variant X1
zinc finger protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cartilage acidic protein 1b, transcript variant X6
cartilage acidic protein 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cartilage acidic protein 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cartilage acidic protein 1b, transcript variant X5
cartilage acidic protein 1b, transcript variant X1
cartilage acidic protein 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
R3H domain and coiled-coil containing 1-like, transcript variant X1
uncharacterized protein r3hcc1l isoform X1
R3H domain and coiled-coil containing 1-like, transcript variant X3
R3H domain and coiled-coil containing 1-like, transcript variant X2
uncharacterized protein r3hcc1l isoform X2
R3H domain and coiled-coil containing 1-like, transcript variant X4
uncharacterized protein r3hcc1l isoform X3
lysyl oxidase-like 4, transcript variant X1
lysyl oxidase-like 4, transcript variant X2
lysyl oxidase-like 4, transcript variant X3
uncharacterized protein LOC641500 homolog, transcript variant X2
uncharacterized protein LOC641500 homolog, transcript variant X1
uncharacterized protein zgc:123010 isoform X2
uncharacterized protein zgc:123010 isoform X1
uncharacterized protein LOC641500 homolog, transcript variant X3
tetratricopeptide repeat protein 31 isoform X3
pyridine nucleotide-disulphide oxidoreductase domain 2
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2
CREB3 regulatory factor-like, transcript variant X2
CREB3 regulatory factor-like, transcript variant X3
CREB3 regulatory factor-like, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 25 member 28, transcript variant X3
solute carrier family 25 member 28, transcript variant X4
solute carrier family 25 member 28, transcript variant X1
solute carrier family 25 member 28, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamic-oxaloacetic transaminase 1, soluble
metal transporter CNNM1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
metal transporter CNNM1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
metal transporter CNNM1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
metal transporter CNNM2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
metal transporter CNNM2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
arsenite methyltransferase, transcript variant X1
arsenite methyltransferase, transcript variant X2
transfer RNA isoleucine (anticodon GAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
steroid 17-alpha-hydroxylase/17,20 lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
steroid 17-alpha-hydroxylase/17,20 lyase, transcript variant X2
steroid 17-alpha-hydroxylase/17,20 lyase, transcript variant X3
steroid 17-alpha-hydroxylase/17,20 lyase
WW domain binding protein 1-like a, transcript variant X3
WW domain binding protein 1-like a, transcript variant X7
WW domain binding protein 1-like a, transcript variant X5
WW domain binding protein 1-like a, transcript variant X1
WW domain binding protein 1-like a, transcript variant X6
WW domain binding protein 1-like a, transcript variant X2
WW domain binding protein 1-like a, transcript variant X4
WW domain binding protein 1-like a isoform X3
WW domain binding protein 1-like a isoform X1
WW domain binding protein 1-like a isoform X7
WW domain binding protein 1-like a isoform X6
WW domain binding protein 1-like a isoform X5
WW domain binding protein 1-like a isoform X2
WW domain binding protein 1-like a isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ADP ribosylation factor like GTPase 3b, transcript variant X2
ADP ribosylation factor like GTPase 3b, transcript variant X1
ADP-ribosylation factor-like protein 3 isoform X1
ADP-ribosylation factor-like protein 3 isoform X2
tripartite motif containing 8b, transcript variant X2
tripartite motif containing 8b, transcript variant X3
tripartite motif containing 8b, transcript variant X1
suppressor of fused homolog (Drosophila), transcript variant X3
suppressor of fused homolog (Drosophila), transcript variant X1
suppressor of fused homolog (Drosophila), transcript variant X2
major facilitator superfamily domain containing 13A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SMC5-SMC6 complex localization factor protein 2
uncharacterized LOC122561346, transcript variant X1
uncharacterized LOC122561346, transcript variant X2
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Gb
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial ribosomal protein L43, transcript variant X1
mitochondrial ribosomal protein L43, transcript variant X2
39S ribosomal protein L43, mitochondrial isoform X2
39S ribosomal protein L43, mitochondrial isoform X1
twinkle mtDNA helicase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
twinkle mtDNA helicase, transcript variant X2
twinkle protein, mitochondrial isoform X1
twinkle protein, mitochondrial isoform X2
leucine zipper, putative tumor suppressor 2a, transcript variant X7
leucine zipper, putative tumor suppressor 2a, transcript variant X2
leucine zipper, putative tumor suppressor 2a, transcript variant X3
leucine zipper, putative tumor suppressor 2a, transcript variant X1
leucine zipper, putative tumor suppressor 2a, transcript variant X8
leucine zipper, putative tumor suppressor 2a, transcript variant X5
leucine zipper, putative tumor suppressor 2a, transcript variant X6
leucine zipper, putative tumor suppressor 2a, transcript variant X9
leucine zipper, putative tumor suppressor 2a, transcript variant X4
leucine zipper putative tumor suppressor 2a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122560989, transcript variant X2
uncharacterized LOC122560989, transcript variant X1
uncharacterized protein LOC122560989 isoform X2
uncharacterized protein LOC122560989 isoform X1
cilia and flagella associated protein 58
cilia- and flagella-associated protein 58
VPS10 domain-containing receptor SorCS1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
VPS10 domain-containing receptor SorCS1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
VPS10 domain-containing receptor SorCS3-like isoform X1
VPS10 domain-containing receptor SorCS1-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
SHOC2 leucine rich repeat scaffold protein, transcript variant X4
SHOC2 leucine rich repeat scaffold protein, transcript variant X2
SHOC2 leucine rich repeat scaffold protein, transcript variant X1
SHOC2 leucine rich repeat scaffold protein, transcript variant X3
SHOC2 leucine rich repeat scaffold protein, transcript variant X5
programmed cell death 4b, transcript variant X1
programmed cell death 4b, transcript variant X2
programmed cell death 4b, transcript variant X3
programmed cell death 4b, transcript variant X4
programmed cell death protein 4b isoform X1
programmed cell death protein 4b isoform X2
structural maintenance of chromosomes protein 3
survival motor neuron domain containing 1, transcript variant X1
survival of motor neuron-related-splicing factor 30 isoform X1
survival motor neuron domain containing 1, transcript variant X2
survival of motor neuron-related-splicing factor 30 isoform X2
max interactor 1, dimerization protein, transcript variant X1
max interactor 1, dimerization protein, transcript variant X2
adducin 3 (gamma) a, transcript variant X5
adducin 3 (gamma) a, transcript variant X2
adducin 3 (gamma) a, transcript variant X4
adducin 3 (gamma) a, transcript variant X7
adducin 3 (gamma) a, transcript variant X1
adducin 3 (gamma) a, transcript variant X3
adducin 3 (gamma) a, transcript variant X6
adducin 3 (gamma) a, transcript variant X8
Copper-only SOD repeat protein, transcript variant X2
Copper-only SOD repeat protein, transcript variant X1
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble
STIM activating enhance, transcript variant X2
STIM activating enhance, transcript variant X1
store-operated calcium entry regulator STIMATE isoform X1
store-operated calcium entry regulator STIMATE isoform X2
musculoskeletal embryonic nuclear protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X3
neural Wiskott-Aldrich syndrome protein-like, transcript variant X2
neural Wiskott-Aldrich syndrome protein-like, transcript variant X1
neural Wiskott-Aldrich syndrome protein-like isoform X2
neural Wiskott-Aldrich syndrome protein-like isoform X1